Evidence map›Paper›PMID 30692120›Full record

ArticleBlood2019

Exploring the "minimal" structure of a functional ADAMTS13 by mutagenesis and small-angle X-ray scattering.

Jian Zhu, Joshua Muia, Garima Gupta, Lisa A Westfield, Karen Vanhoorelbeke, Niraj H Tolia, J Evan Sadler

Open access · bronzeAbstract read
In one paragraph

Article in Blood, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 29 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Mechanisms of ADAMTS13 regulation.Journal of thrombosis and haemostasis : JTH · 2022
    Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. A Single Synonymous Variant (c.354G>A [p.P118P]) inInternational journal of molecular sciences · 2019
    Article
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Jian ZhuDepartment of Medicine, Washington University School of Medicine, St. Louis, MO.ORCID 0000-0001-6679-8498
Joshua MuiaDepartment of Medicine, Washington University School of Medicine, St. Louis, MO.ORCID 0000-0001-5011-2420
Garima GuptaDepartment of Medicine, Washington University School of Medicine, St. Louis, MO.ORCID 0000-0002-6899-9848
Lisa A WestfieldDepartment of Medicine, Washington University School of Medicine, St. Louis, MO.ORCID 0000-0001-9128-1853
Karen VanhoorelbekeLaboratory for Thrombosis Research, Interdisciplinary Research Facility Life Sciences, Katholieke Universiteit Leuven Campus Kulak Kortrijk, Kortrijk, Belgium.ORCID 0000-0003-2288-8277
Niraj H ToliaLaboratory of Malaria Immunology and Vaccinology, National Institute of Allergy and Infectious Disease, National Institutes of Health, Rockville, MD; and.ORCID 0000-0002-2689-1337
J Evan SadlerDepartment of Medicine, Washington University School of Medicine, St. Louis, MO.ORCID 0000-0001-5705-469X
Washington University in St. Louis · USKU Leuven · BENational Institutes of Health · US

Funding

User Training and OutreachP30GM124169 · NIGMS · UNIVERSITY OF CALIF-LAWRENC BERKELEY LAB · PI PAUL David ADAMS, Gregory L Hura · 2017 to 2026
$28.6M
PRE-AND POSTGRADUATE TRAINING IN MOLECULAR HEMATOLOGYT32HL007088 · NHLBI · WASHINGTON UNIVERSITY · PI Grant Anthony Challen, Stephen Oh · 1985 to 2026
$14.1M
Translational Research Skills Development CoreU54HL112303 · NHLBI · WASHINGTON UNIVERSITY · PI SADLER, J EVAN · 2012 to 2016
$8.8M
VON WILLEBRAND FACTOR MULTIMER ASSEMBLY AND STRUCTURER01HL072917 · NHLBI · WASHINGTON UNIVERSITY · PI SADLER, J EVAN · 2003 to 2012
$4.4M
Regulation of ADAMTS13 ActivityR01HL089746 · NHLBI · WASHINGTON UNIVERSITY · PI SADLER, J EVAN · 2007 to 2011
$2.1M
ALLOSTERIC REGULATION OF ADAMTS13R01HL130446 · NHLBI · WASHINGTON UNIVERSITY · PI KORNFELD, STUART A · 2016 to 2019
$1.7M
NHLBI NIH HHS R01 HL072917NHLBI NIH HHS R01 HL089746NHLBI NIH HHS R01 HL130446NHLBI NIH HHS T32 HL007088NHLBI NIH HHS U54 HL112303NIGMS NIH HHS P30 GM124169
6 · The paper itself

Abstract

Human ADAMTS13 is a multidomain protein with metalloprotease (M), disintegrin-like (D), thrombospondin-1 (T), Cys-rich (C), and spacer (S) domains, followed by 7 additional T domains and 2 CUB (complement components C1r and C1s, sea urchin protein Uegf, and bone morphogenetic protein-1) domains. ADAMTS13 inhibits the growth of von Willebrand factor (VWF)-platelet aggregates by cleaving the cryptic Tyr

Indexed as

MutationProtein Structure, TertiaryScattering, Small AngleADAMTS13 ProteinAllosteric RegulationBinding SitesCatalytic DomainHumansModels, MolecularMutagenesisProtein BindingRecombinant Proteinsvon Willebrand FactorADAMTS13 ProteinADAMTS13 protein, humanRecombinant Proteinsvon Willebrand Factor

Identifiers

PMID30692120
PMCPMC6484386
OpenAlexW2912243656

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.